Horizon Europe Call for Proposals: Development of new effective therapies for rare diseases

EJPRD logo

The European Commission (EC) has opened a new funding call titled “Tackling diseases (Two Stage – 2022) (HORIZON-HLTH-2022-DISEASE-06-two-stage)” in the context of the Horizon Europe Framework Programme on the development of new effective therapies for rare diseases.

Support for proposals from EJP RD

As part of EJP RD’s support for rare disease research, multiple EJP RD services are available to aid in the above call for proposals:

  • Data FAIRification: making resources Findable, Accessible, Interoperable and Reusable for humans and machines.
  • Clinical Studies Support Office can assist with the design of clinical trials both in terms of project planning (site selection, cost evaluation etc) as well as study design (methodological and statistical methods).
  • Mentoring for translational research to design proposals from bench to bedside. Our range of experts can assist on a number of topics and review proposals to increase their impact.

Depending on your needs, EJP RD may be able to assist with other services.

More information here: https://www.ejprarediseases.org/horizon-europe-call-for-proposals-development-of-new-effective-therapies-for-rare-diseases/

This entry was posted in General.